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Purpose: To compare the diagnostic performance of two-dimensional 
(2D) mammography, 2D mammography plus digital breast 
tomosynthesis (DBT), and synthetic 2D mammography 
plus DBT in depicting malignant radiographic features.
Materials and 
Methods:
In this multicenter, multireader, retrospective reading 
study (the TOMMY trial), after written informed con-
sent was obtained, 8869 women (age range, 29–85 years; 
mean, 56 years) were recruited from July 2011 to March 
2013 in an ethically approved study. From these women, 
a reading dataset of 7060 cases was randomly allocated 
for independent blinded review of (a) 2D mammography 
images, (b) 2D mammography plus DBT images, and (c) 
synthetic 2D mammography plus DBT images. Reviewers 
had no access to results of previous examinations. Overall 
sensitivities and specificities were calculated for younger 
women and those with dense breasts.
Results: Overall sensitivity was 87% for 2D mammography, 89% 
for 2D mammography plus DBT, and 88% for synthetic 
2D mammography plus DBT. The addition of DBT was 
associated with a 34% increase in the odds of depicting 
cancer (odds ratio [OR] = 1.34, P = .06); however, this 
level did not achieve significance. For patients aged 50–59 
years old, sensitivity was significantly higher (P = .01) for 
2D mammography plus DBT than it was for 2D mam-
mography. For those with breast density of 50% or more, 
sensitivity was 86% for 2D mammography compared with 
93% for 2D mammography plus DBT (P = .03). Specificity 
was 57% for 2D mammography, 70% for 2D mammogra-
phy plus DBT, and 72% for synthetic 2D mammography 
plusmDBT. Specificity was significantly higher than 2D 
mammography (P , .001in both cases) and was observed 
for all subgroups (P , .001 for all cases).
Conclusion: The addition of DBT increased the sensitivity of 2D mam-
mography in patients with dense breasts and the speci-
ficity of 2D mammography for all subgroups. The use of 
synthetic 2D DBT demonstrated performance similar to 
that of standard 2D mammography with DBT. DBT is of 
potential benefit to screening programs, particularly in 
younger women with dense breasts.
q RSNA, 2015
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Current evidence favors the use of 
two-view DBT as an adjunct to 2D mam-
mography rather than as a stand-alone 
imaging modality, although this practice 
almost doubles the radiation dose (14). 
To address this concern, a synthetic 2D 
image can be created from the tomosyn-
thesis data, a procedure that is currently 
being evaluated in the Oslo trial (18,19).
While the STORM and Oslo studies 
demonstrated the improved accuracy of 
2D mammography plus DBT in screen-
ing, studying the performance of DBT 
in specific subgroups of patients re-
quires that data be enriched with can-
cer cases. There is a need to establish 
whether the addition of DBT is equally 
effective in women with different breast 
densities, ages, and tumor subtypes 
and sizes. Our purpose was to com-
pare the diagnostic performance of 2D 
mammography, 2D mammography plus 
DBT, and synthetic 2D mammography 
plus DBT for depicting malignant fea-
tures in different subgroups of women 
invited for screening.
Materials and Methods
Support for this study was provided by 
Hologic (Bedford, Mass), who created 
cancers are not detected at standard 
screening; this percentage is higher in 
women younger than 50 years and with 
dense breasts (3–6).
The development of digital breast 
tomosynthesis (DBT) and its clinical 
application has been summarized in a 
number of review articles, and its per-
formance either relative to or in com-
bination with two-dimensional (2D) 
mammography in clinical studies has 
been reviewed (7–15). Most studies 
were small retrospective reader per-
formance studies with cancer enriched 
datasets rather than screening studies, 
but they provided evidence that DBT 
has the potential to improve the ac-
curacy of mammography by reducing 
screening recall rates and increasing 
cancer detection rates. More recently, 
prospective screening studies demon-
strated improved sensitivity and spec-
ificity with the use of DBT. The Oslo 
Tomosynthesis Screening Trial reported 
a 27% increase in the cancer detection 
rate across all breast densities and a 
15% decrease in the false-positive recall 
rate when DBT was used in combina-
tion with 2D mammography compared 
with 2D mammography alone (16). The 
population-based Screening with Tomo-
synthesis or Mammography (STORM) 
study compared sequential 2D mam-
mography and combined DBT and 2D 
mammography and reported a 34% 
increase in cancer detection across all 
age groups and breast densities and a 
potential to reduce the false-positive re-
call rate by 17% (17).
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Advances in Knowledge
 n The diagnostic accuracy of digital 
breast tomosynthesis (DBT) with 
either two-dimensional (2D) or 
synthetic 2D mammography was 
significantly improved compared 
with 2D mammography alone (P 
, .001 in both cases).
 n The area under the receiver op-
erating characteristics curve 
(AUC) was 0.84 (95% confidence 
interval [CI]: 0.83, 0.86) for 2D 
mammography alone, 0.89 (95% 
CI: 0.87, 0.90) for 2D mammog-
raphy plus DBT, and 0.87 (95% 
CI: 0.86, 0.89) for synthetic 2D 
mammography plus DBT.
 n The addition of DBT increased 
the sensitivity of 2D mammog-
raphy in women with dense 
breasts (86% for 2D mammog-
raphy alone vs 93% for 2D mam-
mography plus DBT) and the 
specificity of 2D mammography 
in all subgroups (58% for 2D 
mammography alone vs 69% for 
2D mammography plus DBT).
 n Overall, the sensitivity and speci-
ficity of synthetic 2D mammog-
raphy plus DBT (88% and 71%, 
respectively) were comparable to 
those of 2D mammography plus 
DBT (89% and 69%, 
respectively).
 n A significant increase in sensi-
tivity was observed for 2D mam-
mography plus DBT (P = .04) 
when the dominant radiologic 
feature was a mass, with 89% 
(range, 86%–92%) sensitivity for 
2D mammography and 92% 
(range, 89%–95%) for 2D mam-
mography plus DBT.
Implications for Patient Care
 n The use of DBT with either 2D 
or synthetic 2D mammography 
may be beneficial to screening 
programs, reducing the number 
of false-positive results.
 n The addition of DBT is of partic-
ular benefit in younger women 
with dense breasts.
 n Synthetic 2D mammography ap-
pears to have diagnostic accuracy 
similar to that of 2D mammog-
raphy when used in conjunction 
with DBT.
Breast screening with mammogra-phy is recognized as an effective method for detecting early-stage 
breast cancer (1). However, the pres-
ence of overlapping breast fibroglandu-
lar tissue can decrease the visibility of 
cancers or simulate the appearance of 
a malignant lesion, reducing sensitivity 
and increasing false-positive results (2). 
It has been reported that 15%–30% of 
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of the total study and 80% for any sub-
group that constitutes at least 11% of 
the total study.
A randomization program man-
aged by the Cambridge Clinical Trials 
Unit assigned weekly reading sets that 
included a mix of healthy, benign, and 
cancer cases. Readers reviewed either 
(a) 2D mammography, (b) 2D mam-
mography plus DBT, or (c) synthetic 
2D mammography plus DBT images 
for any one case (ie, individual cases 
were read by a different reader in each 
arm of the study) and randomized 
cases from all three arms of the study. 
Readers did not review any cases from 
their own center. Readers were blinded 
to the outcome status of each case, and 
cases were independently read without 
access to previous examinations. The 
decision to recall the case or not was 
made, and the location, size, and type 
of suspicious findings were recorded 
with a five-point suspicion score.
Outcome Measures
For cases who underwent biopsy, the 
outcomes from the three arms of the 
reading study were compared with the 
final histopathologic findings to verify 
the presence of benign or malignant 
disease. At assessment investigations, 
including a clinical examination, ad-
ditional mammographic views and ul-
trasonographic scans were obtained 
as appropriate. Negative (benign or 
healthy) cases are routinely reviewed 
at the assessment clinic by two radiol-
ogists before the patient is discharged 
as a failsafe to ensure that nothing was 
overlooked.
Statistical Analysis
Data for all three reading arms for all 
cases were not available because im-
ages were not converted to synthetic 
2D mammography, data were lost in 
transit to reading sites, and there were 
image management issues. The pri-
mary analysis included cases that were 
read in at least two arms of the study 
to avoid introducing bias. The analysis 
was rerun by using only cases that were 
read in all three arms and produced al-
most identical results. For the purposes 
of analysis, a study was categorized as 
program. These readers were among a 
group of readers from the six centers 
who participated in the prospective 
data collection. Each reader attended 
a 1-day DBT reading course and read 
a test set of 80 cases. Readers also 
gained experience by reviewing DBT 
images acquired at their own site dur-
ing recruitment. Images were viewed 
on SecurView DW workstations (Ho-
logic) that were optimized to read both 
2D and DBT images.
Prospective Data Collection
Assessment cases were read by a sin-
gle reader with available 2D and DBT 
images, and family history cases were 
independently read by two readers 
with 2D and DBT images. Synthetic 
2D images were not available during 
prospective data collection. For each 
case, readers marked the location and 
type of abnormalities, gave a five-point 
suspicion score, and assessed breast 
density by using a visual analog scale. 
For family history cases, an overall 
recall or no recall decision was also 
recorded.
Retrospective Reading Study
The planned reading target for this 
study was 7000 cases. The sample size 
calculation was powered to allow sig-
nificant differences to be evaluated for 
subgroup analyses. The smallest antic-
ipated subgroup of cancers was esti-
mated to comprise around 15% of the 
total tumor population. We postulated 
that 2D mammography had sensitivity 
of 85% and that 2D mammography 
plus DBT had sensitivity of 95%. With 
a 5% significance level and two-sided 
testing, 90% power to detect this dif-
ference (ie, 5% missed by DBT and 
15% missed by 2D mammography) as 
significant requires at least 38 cancers 
with discordant findings. Thus, 190 
cancers (38 ÷ 0.2) were needed in the 
subgroup. As was previously stated, 
the smallest subgroup was expected to 
be 15% of the total; therefore, a total 
of 1267 cancer cases were required, 
which implies a total study size of 7000 
cases. A study population of this size 
would have at least 90% power for any 
subgroup that constitutes at least 15% 
synthetic 2D images for the reading 
study. The authors had control of all 
data in the study and the information 
submitted for publication. The study 
was approved and given a favorable 
ethical opinion by Scotland A Research 
Ethics Committee.
Study Design and Participants
The study was designed to produce 
a cancer-rich cohort of cases so 
that comparisons of tumor size and 
characteristics could be analyzed. 
Women who were aged 47 years and 
older in six National Health Service 
breast screening program centers and 
recalled to an assessment clinic for 
a mammographic abnormality found 
at routine 2D screening and women 
who were younger than 50 years old 
with a family history of breast cancer 
and underwent annual mammogra-
phy screening (family history cases) 
were eligible. No women underwent 
DBT before admittance to the study 
because it is not used in the United 
Kingdom screening program. Writ-
ten informed consent was obtained. 
Women with breast implants, those 
who were pregnant, and those who 
were unable to give consent were ex-
cluded. Only one case per woman was 
included in the study.
Image Acquisition
At the assessment or family history 
clinic, all participants underwent stan-
dard two-view 2D mammography of 
both breasts and two-view DBT as a 
single procedure with the same breast 
compression and on the same digital 
mammography unit (Selenia Dimen-
sions; Hologic, Bedford, Mass). Syn-
thetic 2D images were generated from 
the DBT dataset for each case by using 
C-View 2011 image processing software 
(Hologic).
Readers
The 26 retrospective study readers 
comprised radiologists (n = 21), ad-
vanced practitioner radiographers (n = 
3), and breast clinicians (n = 2), with 
an average of 10 years (range, 3–25) 
experience reading film in the Na-
tional Health Service breast screening 
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where microcalcification was the domi-
nant radiologic finding, AUCs were 0.73 
(95% CI: 0.69, 0.77) for 2D mammog-
raphy, 0.75 (95% CI: 0.71, 0.78) for 
2D mammography plus DBT, and 0.74 
(95% CI: 0.70, 0.78) for synthetic 2D 
mammography plus DBT. The AUCs of 
2D mammography plus DBT (P = .5) 
and synthetic 2D mammography plus 
DBT (P = .5) did not significantly differ 
from that of 2D mammography. Differ-
ences in AUCs were mainly driven by 
specificity.
read between 493 and 1078 cases 
(mean, 851) that were evenly distrib-
uted over the three arms of the trial. 
The variation in the number of cases 
read was due to reader availability, the 
amount of storage space on worksta-
tions, and the randomization process 
(whereby no case could be read in the 
center from which it originated). Non-
radiologists tended to have higher recall 
rates in all arms and regardless of can-
cer status (data not shown).
Although the primary aim of this 
study was to address specific sub-
groups, it is of illustrative value to see 
the overall matched comparison of 2D 
mammography with DBT. There were 
1137 cancers and 5691 noncancers with 
reading data for both 2D mammogra-
phy and 2D mammography plus DBT. In 
the cancer group, 921 cancers were de-
picted by both 2D mammography and 
2D mammography plus DBT, 71 were 
depicted by 2D mammography alone, 
95 were depicted by 2D mammography 
plus DBT alone, and 50 were not de-
picted by either modality. The addition 
of DBT conferred a 34% increase in 
the odds of detecting cancer (odds ra-
tio, 1.34; 95% confidence interval [CI]: 
0.97, 1.85; P = .06), a level that did 
not achieve significance, and a substan-
tial improvement in specificity, with a 
56% reduction in the odds of recalling 
noncancers (odds ratio, 0.44; 95% CI: 
0.39, 0.49; P , .001) (Table 2).
Results of ROC analysis showed that 
the AUC was 0.84 (95% CI: 0.82, 0.86) 
for 2D mammography, 0.89 (95% CI: 
0.87, 0.91) for 2D mammography plus 
DBT, and 0.88 (95% CI: 0.86, 0.90) for 
synthetic 2D mammography plus DBT 
(Fig 2). Both DBT arms had signifi-
cantly greater AUCs than did 2D mam-
mography (P , .001 in both cases).
For cases with breast density of 
50% or more, AUCs were 0.83 (95% 
CI: 0.79, 0.86) for 2D mammography, 
0.89 (95% CI: 0.87, 0.92) for 2D mam-
mography plus DBT, and 0.87 (95% CI: 
0.84, 0.90) for synthetic 2D mammog-
raphy plus DBT. Both 2D mammogra-
phy plus DBT and synthetic 2D mam-
mography plus DBT had significantly 
greater AUCs than did 2D mammogra-
phy (P , .001 in both cases). In cases 
positive if the reader decided to recall 
the patient.
Sensitivities and specificities were 
calculated for each of the three reading 
arms: first for all cases, then for subgroups 
according to breast density and the domi-
nant radiologic feature. In addition, sen-
sitivity to cancers was calculated for sub-
groups by size, lymph node status, and 
histologic grade. Because each imaging 
modality was applied to the same cases, 
analysis of binary outcomes was carried 
out with McNemar methods and corre-
sponding conditional logistic regression 
analyses (20,21). The methodology of 
the McNemar analysis implied that, for 
a comparison of two imaging modal-
ities, only cases with no missing data for 
each modality were included. Statistical 
analysis was performed with Stata ver-
sion 10.0 (StateCorp, College Station, 
Tex). We interpreted P values less than 
.05 as indicating significant difference.
Receiver operating characteristics 
(ROC) analysis was performed to com-
pare diagnostic accuracy of the three 
study arms. Areas under the ROC curve 
(AUC) were compared by using the 
method set forth by De Long et al (22).
Results
As shown in Figure 1, a total of 8869 
participants, aged 29–85 years (mean 
age, 56 years), were recruited, with 
7684 assessment cases and 1185 family 
history cases. Exclusions (n = 207) re-
sulted in a prospective dataset of 8662 
cases. A further 1412 cases were ran-
domly excluded to reduce the dataset 
in line with the planned reading target 
of 7000 cases. There were 190 cases for 
which, due to logistics and image trans-
fer issues, data were available from 
only one reading arm. This resulted in 
a final dataset for analysis of 7060 cases 
(assessment, n = 6020; family history, 
n = 1040).
The characteristics of the study 
population are shown in Table 1. Read-
ing data were available for 6927 (98%) 
2D mammography cases, 6959 (99%) 
2D mammography plus DBT cases, and 
6653 (94%) synthetic 2D mammogra-
phy plus DBT cases. Of the 26 readers, 
one read only 85 cases, and the others 
Figure 1
Figure 1: Flowchart shows the allocation of study 
subjects. The numbers in parentheses indicate the 
number of women with cancer.
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Table 2 shows sensitivity and spec-
ificity for all subjects and specific sub-
groups. Overall, sensitivity was 87% 
(95% CI: 85, 89) for 2D mammogra-
phy, 89% (95% CI: 87, 91) for 2D mam-
mography plus DBT, and 88% (95% CI: 
86, 90) for synthetic 2D mammography 
plus DBT. The difference in sensitivity 
between 2D mammography and 2D 
mammography plus DBT was of border-
line significance (P = .06). There was 
no significant difference in sensitivity 
between 2D mammography and syn-
thetic 2D mammography plus DBT (P 
= .6). Specificity was 58% (95% CI: 56, 
60) for 2D mammography, 69% (95% 
CI: 67, 71) for 2D mammography plus 
DBT, and 71% (95% CI: 69, 73) for 
synthetic 2D mammography plus DBT. 
Specificity for 2D mammography plus 
DBT and synthetic 2D mammography 
plus DBT (P , .001 in both cases) was 
significantly higher than it was for 2D 
mammography. The increased speci-
ficity of 2D mammography plus DBT 
and synthetic 2D mammography plus 
DBT was observed in all subgroups of 
breast density, dominant radiologic fea-
ture, and age (P , .001 in all cases). 
For all three modalities, specificity was 
lower for depicting microcalcification 
and higher for depicting distortion/
asymmetry, although a significant im-
provement in specificity for both DBT 
modalities was consistently observed in 
these categories.
For patients aged 50–59 years, 
sensitivity was significantly higher (P = 
.01) for 2D mammography plus DBT 
(91% [95% CI: 88, 94]) than it was for 
2D mammography alone (87% [95% 
CI: 84, 90]), and for those with breast 
density of 50% or more, sensitivity was 
86% (95% CI: 82, 90) for 2D mammog-
raphy and 93% (95% CI: 90, 96) for 2D 
mammography plus DBT (P = .03). For 
depicting 11–20-mm invasive tumors, 
sensitivity was significantly higher (P 
, .001) for 2D mammography plus 
DBT (93% [95% CI: 90, 96]) than it 
was for 2D mammography (86% [95% 
CI: 82, 90]). In cases with grade 2 in-
vasive tumors, sensitivity of 2D mam-
mography plus DBT (91% [95% CI: 88, 
94]) was increased compared to that 
of 2D mammography alone (87% [95% 
Table 1
Participant Characteristics
Characteristic
Assessment Cases Family History Cases
Randomized Cancers Randomized Cancers
Age 
 , 40 years 3 (,1) 1 (,1) 11 (1) 0
 40–49 years 340 (6) 27 (2) 938 (94) 1 (50)
 50–59 years 3568 (59) 462 (40) 44 (4) 1 (50)
 60–69 years 1714 (29) 519 (45) 3 (, 1) 0
  70 years 364 (6) 141 (12)     0 0
 Unknown      31     9   44 0
Breast density
 0%–24% 1,636 (27) 378 (33) 233 (23) 0
 25%–49% 2,556 (43) 439 (38) 418 (42) 1 (50)
 50%–74% 1,376 (23) 271 (24) 271 (27) 1 (50)
 75%–100% 396 (7) 63 (5) 83 (8) 0
 Unknown      56     8   35 0
Cancer type
 Invasive ductal* … 788 (68) … 1 (50)
 Invasive lobular* … 109 (9) …
 Invasive other* … 59 (5) …
 DCIS … 203 (18) … 1 (50)
Invasive cancer size
 1–5 mm … 73 (8) … 0
 6–10 mm … 243 (26) … 0
 11–20 mm … 434 (46) … 1 (100)
 21–50 mm … 183 (19) … 0
 . 50 mm … 10 (1) … 0
 Unknown …   13 … 0
DCIS size
 1–5 mm … 30 (15) … 0
 6–10 mm … 30 (15) … 0
 11–20 mm … 47 (24) … 0
 21–50 mm … 78 (39) … 1 (100)
 .50 mm … 15 (7) … 0
 Unknown …     3 … 0
Invasive cancer grade
 1 … 242 (26) … 0
 2 … 504 (54) … 2 (100)
 3 … 180 (20) … 0
 Unknown …   30 … 0
DCIS grade
 Low … 10 (8) … 0
 Intermediate … 31 (22) … 1 (100)
 High … 97 (70) … 0
 Unknown …   65 … 0
Lymph node status†
 Normal … 514 (58) … 0
 , four positive nodes … 292 (33) … 1 (100)
 four positive nodes … 77 (9) … 0
 Unknown …   73 … 0
Dominant imaging feature
 Circumscribed mass 1814 (30) 145 (13) 84 (8) 0
 Spiculated mass 712 (12) 508 (44) 3 (, 1) 0
Table 1 (continues)
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mammography plus DBT and could re-
flect a shortcoming of the synthetic al-
gorithm. It is not possible to comment 
on its sensitivity in women younger 
than 50 years old because only 29 can-
cers were found in women in this age 
group.
The significant improvement in 
specificity observed for 2D mammogra-
phy plus DBT compared with that of 2D 
mammography alone is consistent with 
published studies (16,17,23,27). The 
results of the Oslo (16) and STORM 
(17) trials indicate the potential of 2D 
mammography plus DBT to reduce 
false-positive recall rates, although the 
magnitude of this reduction is likely to 
vary depending on the recall or arbitra-
tion policy in practice. Our study was 
not a screening trial, but the results are 
consistent with a relative improvement 
in specificity of 19%, suggesting that al-
most one in five of current false-positive 
recalls may be avoided by the addition 
of DBT. In the United States, where re-
call rates are often higher than those in 
Europe, the addition of DBT may have 
a greater effect. The improvement in 
specificity was observed irrespective 
of breast density, age, dominant radio-
logic feature, or invasive status, adding 
to the overall results of other studies 
(23,27,28).
We also compared the diagnostic 
performance of synthetic 2D mammog-
raphy plus DBT with that of 2D mam-
mography alone. There was no signif-
icant difference in sensitivity between 
synthetic 2D mammography plus DBT 
and 2D mammography, but specificity 
was significantly higher. In comparison 
with 2D mammography plus DBT, there 
was no significant difference in sensitiv-
ity or specificity. Gur et al (18) reported 
that synthetic 2D mammography plus 
DBT has lower sensitivity but compara-
ble specificity compared with those of 
standard 2D mammography plus DBT; 
however, two recent studies that used 
the same software version as our study 
demonstrated comparable performance 
(29,30). Our subgroup analysis sug-
gests that synthetic 2D mammography 
plus DBT and 2D mammography plus 
DBT had better sensitivity for depict-
ing 11–20-mm invasive cancers than did 
occur in cases with a breast density less 
than 50% compared with the other two 
modalities.
Discussion
In this retrospective reading study, we 
demonstrated a clear improvement in 
diagnostic accuracy when DBT is used 
in conjunction with 2D or synthetic 
2D mammography compared with 2D 
mammography alone, with a significant 
reduction (56%) in the odds of having a 
false-positive recall. This reduction was 
mainly driven by a dramatic improve-
ment in specificity.
Subgroup analyses indicated that 
the sensitivity of 2D mammography plus 
DBT was better than that of 2D mam-
mography for depicting grade 2 invasive 
cancers, 11–20-mm invasive cancers, 
and lesions whose dominant radiologic 
feature was distortion or asymmetric 
density. Improved depiction of spiculated 
masses and distortions at 2D mammog-
raphy plus DBT was also reported by 
Rose et al (23) and attributed to clearer 
definition of lesion shape and margins. 
The addition of DBT appears to have had 
little impact on the depiction of cancers 
larger than 20 mm. Our data are con-
sistent with those of other studies that 
reported that DBT is better for depicting 
masses rather than microcalcification as 
the main radiologic feature (24–26).
We observed a significant improve-
ment in sensitivity of 2D mammogra-
phy plus DBT in women aged 50–59 
years and with breast density of 50% 
or more; however, this improved sen-
sitivity was not seen with synthetic 2D 
CI: 84, 90]; P = .01). In cases where 
the dominant radiologic feature was a 
mass, sensitivity of 2D mammography 
plus DBT (92% [95% CI: 89, 95]) was 
significantly increased (P = .04) com-
pared with that of 2D mammography 
alone (89% [95% CI: 86, 92]). For 
synthetic 2D mammography plus DBT, 
sensitivity of 2D mammography alone 
(92% [95% CI: 89, 95]) was signifi-
cantly higher (P = .006) than it was for 
synthetic 2D mammography plus DBT 
in cases with 11–20-mm invasive can-
cer. No other significant differences in 
sensitivity were noted.
Of the 1112 invasive cancers with 
reading data available, 1079 (97%) 
were depicted by at least one arm, and 
840 (75%) were depicted by all three. 
There were 142 (13%) cancers missed 
at 2D mammography, 118 (11%) were 
missed at 2D mammography plus DBT, 
and136 (12%) were missed at synthetic 
2D mammography plus DBT. For the 
200 cases of ductal carcinoma in situ, 
the distribution was similar, with 143 
(71%) cancers depicted by all three 
arms, eight (4%) depicted only at 
2D mammography, and 14 (7%) de-
tected at both DBT arms (but not 2D 
mammography).
Table 3 shows the characteristics 
of the cancers missed at each imag-
ing modality and those depicted at all 
three modalities. The major differences 
are that cancers that were missed at 
2D mammography tended to be 11–20 
mm or have a mass as the dominant 
radiologic feature, whereas those that 
were missed at 2D mammography plus 
DBT were less likely to be grade 2 or 
Characteristic
Assessment Cases Family History Cases
Randomized Cancers Randomized Cancers
 Microcalcification 1006 (17) 282 (24) 40 (4) 1 (50)
 Distortion 514 (8) 109 (9) 10 (1) 1 (50)
 Asymmetric density 1837 (31) 107 (9) 26 (3) 0
 None 137 (2) 7 (1) 877 (84) 0
Note.—Data are numbers of cases, and data in parentheses are percentages. Percentages were reported for known data.
* With or without ductal carcinoma in situ (DCIS).
† For invasive cancers only.
Table 1 (continued)
Participant Characteristics
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by three readers from three different 
sites, thereby avoiding carry over and 
reducing the risk for individual reader 
bias. The 26 readers were high-volume 
readers with varying amounts of ex-
perience. Our assessment of reader 
performance with the addition of DBT 
was conducted in a pragmatic way, and 
we accept that performance varies not 
only among readers but also for individ-
uals from day to day. By using a large 
number of highly trained readers who 
read large volumes of screening mam-
mograms in the regulated environment 
2D mammography alone. However, syn-
thetic 2D mammography plus DBT was 
inferior to both 2D mammography and 
2D mammography plus DBT for depict-
ing microcalcifications and 11–20-mm 
ductal carcinoma in situ.
One strength of this study is that 
there were sufficient numbers of can-
cers for planned subanalyses, and the 
distribution of cancer cases in terms 
of invasion, size, grade, and lymph 
node status was similar to that in the 
United Kingdom screening program 
(31). Each case was independently read 
Figure 2
Figure 2: Graphs show the ROC analysis curves for (a) all cases in 
the three arms of the study, (b) cases with visually assessed breast 
density of 50% or more in all three arms of the study, and (c) cases 
with microcalcification as the dominant radiologic feature in all three 
arms of the study.
of the national screening program, we 
believe that our result is valid and repre-
sents average performance in the United 
Kingdom.
The weaknesses of this study are 
that the it was retrospective, meaning 
that readers knew that their decisions 
had no clinical implications, and that 
the cases were selected by using 2D 
mammography, which means that our 
sensitivity comparisons are conserva-
tive compared with those of screening 
studies, in which additional cancers 
may be depicted at DBT (16,17). This 
is also a highly enriched study, since 
most cases were recalled because of 
abnormal mammography findings.
With the use of assessment cases 
for this study, we effectively used 2D 
mammography to find all the cases in 
100% of the screened women. When 
we used 2D mammography plus DBT 
in the 5% of women who were recalled 
from screening, the readers were, in 
principle, able to find all the cancers 
that were identified as suspicious le-
sions at 2D mammography for the 
entire population. Readers could only 
find cancers that were only detectable 
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subsequent round screening and collec-
tion of interval cancers is required to 
establish evidence-based recommenda-
tions for population screening. In partic-
ular, the diagnostic performance of syn-
thetic 2D mammography for depicting 
microcalcifications could be improved. 
This study demonstrated that the addi-
tion of DBT is particularly valuable in 
certain groups of women, thereby facil-
itating the introduction of a more per-
sonalized approach to screening.
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We found that the performance of 
2D mammography plus DBT was bet-
ter than that of 2D mammography in 
terms of specificity, with significant 
improvements in sensitivity for depict-
ing specific categories of tumor, and 
that synthetic 2D mammography was 
comparable to conventional 2D mam-
mography when used in conjunction 
with DBT. The improved specificity of 
integrated 2D mammography plus DBT 
was equally effective across all age 
groups, but the improved sensitivity 
seen in women aged 50–59 years and 
in those with dense breasts suggests 
that this technology could be directed 
toward younger women and to screen-
ing of women with a family history of 
breast cancer. However, the potential 
to reduce the burden of false-positive 
recalls is of considerable importance to 
screening programs.
Further evaluation of DBT in large-
scale prospective randomized trials with 
at DBT in the 5% of women who were 
recalled. Thus, we did not perform 
DBT in the other 95% of women who 
were not recalled, and there may be 
20 times as many cancers that are 
only detectable at DBT in the entire 
screened population. In this study, the 
sensitivity improvement with the use 
of 2D mammography plus DBT was 
only 2%. In actual screening, we can 
expect up to 20 times as many cases of 
this type of cancer, leading to as much 
as a 40% increase in cancer detection 
for 2D mammography plus DBT com-
pared with 2D mammography alone. 
This calculation shows that, when one 
takes account of the method of case 
selection, the sensitivity improvement 
found in this study is consistent with 
those of published screening studies, 
which reported increases of about 
25%–40% (16,17). Almost all previous 
nonscreening studies are also affected 
by such case selection issues.
Table 3
Characteristics of Invasive Cancers Missed at Each Imaging Modality and Found at 
All Modalities
Characteristic
Cancer Missed at Each Modality
Found at  
All Modalities2D Mammography
2D Mammography  
Plus DBT
Synthetic 2D  
Mammography  
Plus DBT
Size
 1–10 mm 47 (39) 47 (50) 48 (47) 207 (30)
 11–20 mm 60 (50) 30 (32) 34 (34) 326 (47)
 .20 mm 14 (11) 17 (18) 19 (19) 155 (23)
Node status
 Negative 62 (54) 51 (56) 55 (56) 388 (60)
 1–3 positive nodes 41 (36) 35 (38) 35 (35) 201 (31)
 .3 positive nodes 11 (10) 5 (6) 9 (9) 55 (9)
Grade
 1 34 (29) 26 (29) 27 (27) 164 (24)
 2 67 (56) 43 (48) 57 (56) 373 (55)
 3 18 (15) 21 (23) 17 (17) 140 (21)
Breast density
 ,50% 80 (66) 69 (73) 70 (66) 488 (70)
 50% 42 (34) 26 (27) 36 (34) 195 (30)
Dominant imaging feature
 Mass 68 (55) 45 (47) 52 (49) 479 (69)
 Microcalcifications 12 (10) 12 (13) 16 (15) 88 (13)
 Distortion or ASD 42 (34) 37 (39) 37 (35) 126 (18)
 None 1 (1) 1 (1) 1 (1) 4 (1)
Note.—Data are numbers of patients, and data in parentheses are percentages. ASD = asymmetrical density.
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